Search Page

1

Cite

Share

Procalcitonin levels in COVID-19 patients.

Hu R, Han C, Pei S, Yin M, Chen X. Hu R, et al. Among authors: yin m. Int J Antimicrob Agents. 2020 Aug;56(2):106051. doi: 10.1016/j.ijantimicag.2020.106051. Epub 2020 Jun 10. Int J Antimicrob Agents. 2020. PMID: 32534186 Free PMC article.

Cite

Share

2

Cite

Share

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.

Liu L, Wang P, Nair MS, Yu J, Rapp M, Wang Q, Luo Y, Chan JF, Sahi V, Figueroa A, Guo XV, Cerutti G, Bimela J, Gorman J, Zhou T, Chen Z, Yuen KY, Kwong PD, Sodroski JG, Yin MT, Sheng Z, Huang Y, Shapiro L, Ho DD. Liu L, et al. Among authors: yin mt. Nature. 2020 Aug;584(7821):450-456. doi: 10.1038/s41586-020-2571-7. Epub 2020 Jul 22. Nature. 2020. PMID: 32698192

Cite

Share

3

Cite

Share

Metabolite sensing and signaling in cancer.

Wang YP, Li JT, Qu J, Yin M, Lei QY. Wang YP, et al. Among authors: yin m. J Biol Chem. 2020 Aug 14;295(33):11938-11946. doi: 10.1074/jbc.REV119.007624. Epub 2020 Jul 7. J Biol Chem. 2020. PMID: 32641495 Free PMC article. Review.

Cite

Share

4

Cite

Share

Erastin induces ferroptosis via ferroportin-mediated iron accumulation in endometriosis.

Li Y, Zeng X, Lu D, Yin M, Shan M, Gao Y. Li Y, et al. Among authors: yin m. Hum Reprod. 2021 Mar 18;36(4):951-964. doi: 10.1093/humrep/deaa363. Hum Reprod. 2021. PMID: 33378529

Cite

Share

5

Cite

Share

Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5.

Liu Y, Liu X, Zhang N, Yin M, Dong J, Zeng Q, Mao G, Song D, Liu L, Deng H. Liu Y, et al. Among authors: yin m. Acta Pharm Sin B. 2020 Dec;10(12):2299-2312. doi: 10.1016/j.apsb.2020.06.014. Epub 2020 Jun 30. Acta Pharm Sin B. 2020. PMID: 33354502 Free PMC article.

Cite

Share

6

Cite

Share

Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics.

Zhu S, Guo Y, Zhang X, Liu H, Yin M, Chen X, Peng C. Zhu S, et al. Among authors: yin m. Cancer Lett. 2021 Apr 10;503:240-248. doi: 10.1016/j.canlet.2020.11.018. Epub 2020 Nov 24. Cancer Lett. 2021. PMID: 33246091 Review.

Cite

Share

7

Cite

Share

BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway.

Deng G, Zeng F, Su J, Zhao S, Hu R, Zhu W, Hu S, Chen X, Yin M. Deng G, et al. Among authors: yin m. Theranostics. 2020 Sep 15;10(25):11428-11443. doi: 10.7150/thno.47432. eCollection 2020. Theranostics. 2020. PMID: 33052224 Free PMC article.

Cite

Share

8

Cite

Share

Vitamin D Status and COVID-19 Clinical Outcomes in Hospitalized Patients.

Szeto B, Zucker JE, LaSota ED, Rubin MR, Walker MD, Yin MT, Cohen A. Szeto B, et al. Among authors: yin mt. Endocr Res. 2021 Feb-May;46(2):66-73. doi: 10.1080/07435800.2020.1867162. Epub 2020 Dec 30. Endocr Res. 2021. PMID: 33380209 Free PMC article.

Cite

Share

9

Cite

Share

Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1.

Ye Y, Kuang X, Xie Z, Liang L, Zhang Z, Zhang Y, Ma F, Gao Q, Chang R, Lee HH, Zhao S, Su J, Li H, Peng J, Chen H, Yin M, Peng C, Yang N, Wang J, Liu J, Liu H, Han L, Chen X. Ye Y, et al. Among authors: yin m. Genome Med. 2020 Sep 28;12(1):83. doi: 10.1186/s13073-020-00780-z. Genome Med. 2020. PMID: 32988398 Free PMC article.

Cite

Share

10

Cite

Share

Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury.

Hu Y, Yang C, Amorim T, Maqbool M, Lin J, Li C, Fang C, Xue L, Kwart A, Fang H, Yin M, Janocha AJ, Tsuchimoto D, Nakabeppu Y, Jiang X, Mejia-Garcia A, Anwer F, Khouri J, Qi X, Zheng QY, Yu JS, Yan S, LaFramboise T, Anderson KC, Herlitz LC, Munshi NC, Lin J, Zhao J. Hu Y, et al. Among authors: yin m. Cancer Res. 2021 Feb 1;81(3):713-723. doi: 10.1158/0008-5472.CAN-20-1010. Epub 2020 Dec 7. Cancer Res. 2021. PMID: 33288657 Free PMC article.

Cite

Share